Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

BACKGROUND: Robotic stereotactic ablative radiotherapy (SABR) is currently under investigation as a noninvasive treatment option for patients with renal cell carcinoma (RCC). For radiation therapy of RCC, tumor motion and the need for high ablative doses while preserving the remaining renal parenchy...

Descripción completa

Detalles Bibliográficos
Autores principales: Senger, C., Conti, A., Kluge, A., Pasemann, D., Kufeld, M., Acker, G., Lukas, M., Grün, A., Kalinauskaite, G., Budach, V., Waiser, J., Stromberger, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805546/
https://www.ncbi.nlm.nih.gov/pubmed/31638979
http://dx.doi.org/10.1186/s12894-019-0531-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805546/
https://www.ncbi.nlm.nih.gov/pubmed/31638979
http://dx.doi.org/10.1186/s12894-019-0531-z

Ejemplares similares